Brainsway Ltd.: The company continues with its lease-based model; we expect an operational balance by 2018; Credit line granted will support rapid growth. Target price unchanged.

• jaimeuss_admin
• 30 בAugust 2018
• Research
• 0 Comments

Continue Reading

BioLineRx Ltd.: Continued execution of multiple clinical development programs for the Company’s lead project – BL-8040; Investment by a principal investor reflects confidence in the company’s strategy. Target Price unchanged.

• jaimeuss_admin
• 30 בAugust 2018
• Research
• 0 Comments

Continue Reading